Financials
- Market Capitalization 2.07 B
- Employee 167
- Founded 2019
- CEO N/A
- Website www.zenasbio.com
- Headquarter Delaware, United States
- FIGI BBG01J1MG9D6
- Industry Biotecnología
Ingresos totales
Beneficio neto
Beneficio básico por acción
Deuda total
Flujo de caja libre
Efectivo y equivalentes
Ratio precio/beneficio
-2.64
Relación precio/flujo de caja
—
Related tickers
| # | Nombre | Precio | 24h % | 7d % | 1M % | 1A % | Capitalización | Últimos 7 días | |
|---|---|---|---|---|---|---|---|---|---|
| 1939 | MESO Mesoblast Limited - American Depositary Shares | 16.60 USD | -0.95% | -3.43% | +17.56% | +27.20% | 2.15 B USD | ||
| 1944 | AUPH Aurinia Pharmaceuticals Inc - Common Shares | 15.97 USD | -0.87% | -4.83% | +8.49% | +33.86% | 2.12 B USD | ||
| 1955 | ZYME Zymeworks Inc. - Common Stock | 29.80 USD | +1.33% | +12.54% | +35.76% | +67.98% | 2.11 B USD | ||
| 1958 | URGN UroGen Pharma Ltd. - Ordinary Shares | 43.17 USD | +0.19% | -6.66% | +14.48% | +127.21% | 2.11 B USD |